Genotypes coding for low serum levels of mannose-binding lectin are underrepresented among individuals suffering from noninfectious systemic inflammatory response syndrome

Clinical and Vaccine Immunology

Volumn 17, Issue 3, 2010, Pages 447-453

  Smithson, Alex ^a   Perello, Rafael ^b   Aibar, Jesus ^b   Espinosa, Gerard ^b   Tassies, Dolors ^b   Freire, Carolina ^b   Castro, Pedro ^b   Suarez, Belen ^b   Lozano, Francisco ^b,c   Nicolas, Josep Maria ^b  

^a HOSPITAL DE L ESPERIT SANT   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN ASSOCIATED PROTEASE 2; PROTEINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC CODE; GENOTYPE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SEPTIC SHOCK; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTENSIVE CARE UNITS; MALE; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; YOUNG ADULT;

EID: 77649268278     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00375-09     Document Type: Article

References (56)

1. Aittoniemi, J., H. Soranummi, A. T. Rovio, M. Hurme, T. Pessi, M. Nieminen, and J. Karjalainen. 2005. Mannose-binding lectin 2 (MBL2) gene polymorphism in asthma and atopy among adults. Clin. Exp. Immunol. 142:120-124.
2. Arnalich, F., D. Lopez-Maderuelo, R. Codoceo, J. Lopez, L. M. Solis-Garrido, C. Capiscol, C. Fernandez-Capitan, R. Madero, and C. Montiel. 2002. Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin. Exp. Immunol. 127:331-336.
3. Burgner, D., and M. Levin. 2003. Genetic susceptibility to infectious diseases. Pediatr. Infect. Dis. J. 22:1-6.
4. Calandra, T., and J. Cohen. 2005. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit. Care Med. 33:1538-1548.
5. Cervera, C., F. Lozano, N. Saval, I. Gimferrer, A. Ibañez, B. Suarez, L. Linares, F. Cofan, M. J. Ricart, N. Esforzado, M. A. Marcos, T. Pumarola, F. Oppenheimer, J. M. Campistol, and A. Moreno. 2007. The influence of innate immunity gene receptors polymorphisms in renal transplant infections. Transplantation 83:1493-1500.
6. Dellinger, R. P., J. M. Carlet, H. Masur, H. Gerlach, T. Calandra, J. Cohen, J. Gea-Banacloche, D. Keh, J. C. Marshall, M. M. Parker, G. Ramsay, J. L. Zimmerman, J. L. Vincent, and M. M. Levy. 2004. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Surviving Sepsis Campaign Management Guidelines Committee. Crit. Care Med. 32: 858-873.
7. Dulhunty, J. M., J. Lipman, S. Finfer, and the Sepsis Study Investigators for the ANZICS Clinical Trials Group. 2008. Does severe non-infectious SIRS differ from severe sepsis? Results from a multi-centre Australian and New Zealand intensive care unit study. Intensive Care Med. 34:1654-1661.
8. Eisen, D. P., M. M. Dean, M. A. Boermeester, K. J. Fidler, A. C. Gordon, G. Kronborg, J. F. Kun, Y. L. Lau, A. Payeras, H. Valdimarsson, S. J. Brett, W. K. Ip, J. Mila, M. J. Peters, S. Saevarsdottir, J. W. van Till, C. J. Hinds, and E. S. McBryde. 2008. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin. Infect. Dis. 47:510-516.
9. Eisen, D. P., and R. M. Minchinton. 2003. Impact of mannose-binding lection on susceptibility to infectious diseases. Clin. Infect. Dis. 37:1496-1505.
10. Garcia-Laorden, M. I., J. Sole-Violan, F. Rodriguez de Castro, J. Aspa, M. L. Briones, A. Garcia-Saavedra, O. Rajas, J. Blanquer, A. Caballero-Hidalgo, J. A. Marcos-Ramos, J. Hernandez-Lopez, and C. Rodriguez-Gallego. 2008. Mannose-binding lectin and mannose-binding lectin associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults. J. Allergy Clin. Immunol. 122:368-374.
11. Garcia-Laorden, M. I., A. Garcia-Saavedra, F. R. de Castro, J. S. Violan, O. Rajas, J. Blanquer, L. Borderias, and C. Rodriguez-Gallego. 2006. Low clinical penetrance of mannose-binding lectin associated serine protease 2 deficiency. J. Allergy Clin. Immunol. 118:1383-1386.
12. Garcia-Segarra, G., G. Espinosa, D. Tassies, J. Oriola, J. Aibar, A. Bove, P. Castro, J. C. Reverter, and J. M. Nicolas. 2007. Increased mortality in septic shock with the 4G/4G genotype of plasminogen activator inhibitor 1 in patients of white descent. Intensive Care Med. 33:1354-1362.
13. Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hugues. 1988. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 16:128-140.
14. Garred, P. 2008. Mannose-binding lectin genetics: from A to Z. Biochem. Soc. Trans. 36:1461-1466.
15. Garred, P., H. O. Madsen, U. Balslev, B. Hofmann, C. Pedersen, J. Gerstoft, and A. Svejgaard. 1997. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 349: 236-240.
16. Garred, P., H. O. Madsen, P. Halberg, J. Petersen, G. Kronborg, A. Svejgaard, V. Andersen, and S. Jacobsen. 1999. Mannose binding polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum. 42:2145-2152.
17. Garred, P., J. Strom, L. Quist, E. Taaning, and H. O. Madsen. 2003. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome in patients with systemic inflammatory response syndrome. J. Infect. Dis. 188:1394-1403.
18. Geleijns, K., A. Roos, J. J. Houwing-Duistermaat, W. van Rijs, A. P. Tio-Guillen, J. D. Laman, P. A. van Doorn, and B. C. Jacobs. 2006. Mannose binding lectin contributes to the severity of Guillain-Barre syndrome. J. Immunol. 177:4211-4217.
19. Gordon, A. C., U. Waheed, T. K. Hansen, G. A. Hitman, C. S. Garrad, M. W. Turner, N. J. Klei, S. J. Brett, and C. J. Hinds. 2006. Mannose-binding lectin polymorphisms in severe sepsis: relationship to levels, incidence, and outcome. Shock 25:88-93.
20. Granell, M., A. Urbano-Ispizua, B. Suarez, M. Rovira, F. Fernandez-Aviles, C. Martinez, M. Ortega, C. Uriburu, A. Gaya, J. M. Roncero, A. Navarro, E. Carreras, J. Mensa, J. Vives, C. Rozman, E. Montserrat, and F. Lozano. 2006. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. Exp. Hematol. 34:1435-1441.
21. Guardia, A., and F. Lozano. 2003. Mannose binding lectin deficiencies in infectious and inflammatory disorders. Rev. Med. Microbiol. 14:41-52.
22. Hart, M. L., K. A. Ceonzo, L. A. Shaffer, K. Takahashi, R. P. Rother, W. R. Reenstra, J. A. Buras, and G. L. Stahl. 2005. Gastrointestinal ischemiareperfusion injury is lectin pathway dependent without involving C1q. J. Immunol. 174:6373-6380.
23. Hart, M. L., M. C. Walsh, and G. L. Stahl. 2004. Initiation of complement activation following oxidative stress. In vitro and in vivo observations. Mol. Immunol. 41:165-171.
24. Hellemann, D., A. Larsson, H. O. Madsen, J. Bonde, J. O. Jarlov, J. Wiis, T. Faber, J. Wetterslev, and P. Garred. 2007. Heterozygosity of mannosebinding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients. Hum. Mol. Genet. 16:3071-3080.
25. Henckaerts, L., K. R. Nielsen, R. Steffensen, K. Van Steen, C. Mathieu, A. Giulietti, P. J. Wouters, I. Milants, I. Vanhorebeek, L. Langouche, S. Vermeire, P. Rutgeerts, S. Thiel, A. Wilmer, T. K. Hansen, and G. Van den Berghe. 2009. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit. Care Med. 37: 192-201.
26. Horcajada, J. P., F. Lozano, A. Muñoz, B. Suarez, C. Fariñas-Alvarez, M. Almela, A. Smithson, E. Martinez, J. Mallolas, J. Mensa, and J. M. Gatell. 2009. Polymorphic receptors of the innate immune system (MBL/MASP-2 and TLR2/4) and susceptibility to pneumococcal bacteremia in HIV-infected patients: a case-control study. Curr. HIV Res. 7:218-223.
27. Jack, D. L., R. C. Read, A. J. Tenner, M. Frosch, M. W. Turner, and N. J. Klein. 2001. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J. Infect. Dis. 184:1152-1162.
28. Koch, A., M. Melbye, P. Sorensen, P. Homoe, H. O. Madsen, K. Molbak, C. H. Hansen, L. H. Andersen, G. W. Hahn, and P. Garred. 2001. Acute respiratory tract infections and mannosse-binding lectin insufficiency during early childhood. JAMA 285:1316-1321.
29. Krarup, A., R. Wallis, J. Presanis, P. Gal, and R. B. Sim. 2007. Simultaneous activation of complement and coagulation by MBL-associated serin proteases 2. PLoS One 2:e623.
30. Levy, M. M., M. P. Fink, J. C. Marshall, E. Abraham, D. Angus, D. Cook, J. Cohen, S. M. Opal, J. L. Vincent, and G. Ramsay. 2003. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 31:1250-1256.
31. Lozano, F., B. Suarez, A. Muñoz, J. C. Jensenius, J. Mensa, J. Vives, and J. P. Horcajada. 2005. Novel MASP2 variants detected among North African and sub-Saharan individuals. Tissue Antigens 66:131-135.
32. Madsen, H. O., P. Garred, S. Thiel, J. A. Kurtzhals, L. U. Lamm, L. P. Ryder, and A. Svejgaard. 1995. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J. Immunol. 155:3013-3020.
33. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348:1546-1554.
34. Matsushita, M. 1996. The lectin pathways of the complement system. Microbiol. Immunol. 40:887-893.
35. Mira, J. P., A. Cariou, F. Grall, C. Delclaux, M. R. Losser, F. Heshmati, C. Cheval, M. Monchi, J. L. Teboul, F. Riche, G. Leleu, L. Arbibe, A. Mignon, M. Delpech, and J. F. Dhainaut. 1999. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282:561-568.
36. Moller-Kristensen, M., W. Wang, M. Ruseva, S. Thiel, S. Nielsen, K. Takahashi, L. Shi, A. Ezekowitz, J. C. Jensenius, and M. Gadjeva. 2005. Mannanbinding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand. J. Immunol. 61:426-434.
37. Nauta, A. J., N. Raaschou-Jensen, A. Roos, M. R. Daha, H. O. Madsen, M. C. Borrias-Essers, L. P. Ryder, C. Koch, and P. Garred. 2003. Manosse-binding lectin engagement with late apoptotic and necrotic cells. Eur. J. Immunol. 33:2853-2863.
38. Neth, O., D. L. Jack, A. W. Dodds, H. Holzel, N. J. Klein, and M. W. Turner. 2000. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 68:688-693.
39. Ogden, C. A., A. de Cathelineau, P. R. Hoffmann, D. Bratton, B. Ghebrehiwet, V. A. Fadok, and P. M. Henson. 2001. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194:781-795.
40. Ono, K., C. Nishitani, H. Mitsuzawa, T. Shimizu, H. Sano, H. Suzuki, T. Kodama, N. Fjii, K. Fukase, K. Hirata, and Y. Kuroki. 2006. Mannose-binding lectin augments the uptake of lipid A, Staphylococcus aureus, and Escherichia coli by Kupffer cells through increased cell surface expression of scavenger receptor A. J. Immunol. 177:5517-5523.
41. Peterslund, N. A., C. Koch, J. C. Jensenius, and S. Thiel. 2001. Association between deficiency of mannose-binding lection and severe infection after chemotherapy. Lancet 358:637-638.
42. Russell, J. A. 2006. Management of sepsis. N. Engl. J. Med. 355:1699-1713.
43. Schlapbach, L. J., C. Aebi, M. Otth, K. Leibundgut, A. Hirt, and R. A. Ammann. 2007. Deficiency of mannose-binding lectin associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients. Pediatr. Infect. Dis. J. 26:989-994.
44. Smithson, A., A. Muñoz, B. Suarez, S. M. Soto, R. Perello, A. Soriano, J. A. Martinez, J. Vila, J. P. Horcajada, J. Mensa, and F. Lozano. 2007. Association between mannose-binding lectin deficieny and septic shock following acute pyelonephritis due to Escherichia coli. Clin. Vaccine Immunol. 14: 256-261.
45. Sorensen, T. I., G. G. Nielsen, P. K. Andersen, and T. W. Teasdale. 1988. Genetic and environmental influences on premature death in adult adoptees. N. Engl. J. Med. 318:727-732.
46. Sorensen, G. L., I. Petersen, S. Thiel, M. Fenger, K. Christensen, K. O. Kyvik, T. I. Sorensen, U. Holmskov, and J. C. Jensenius. 2007. Genetic influences on mannan-binding lectin and mannan-binding lectin associated serine protease-2 activity. Genet. Epidemiol. 31:31-41.
47. Steffensen, R., S. Thiel, K. Varming, C. Jersild, and J. C. Jensenius. 2000. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J. Immunol. Methods 241:33-42.
48. Stengaard-Pedersen, K., S. Thiel, M. Gadjeva, M. Moller-Kristensen, R. Sorensen, L. T. Jensen, A. G. Sjoholm, L. Fugger, and J. C. Jensenius. 2003. Inherited deficiency of mannan-binding-associated serine proteases 2. N. Engl. J. Med. 349:554-560.
49. Stuart, L. M., K. Takahashi, L. Shi, J. Savill, and R. A. Ezekowitz. 2005. Mannose-binding lectin deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J. Immunol. 174:3220-3226.
50. Sutherland, A. M., K. R. Walley, and J. A. Russell. 2005. Polymorphisms in CD14, mannose-binding lectin and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit. Care Med. 33:638-644.
51. Thiel, S., R. Steffensen, I. J. Christensen, W. K Ip, Y. L. Lau, I. J. Reason, H. Eiberg, M. Gadjeva, M. Ruseva, and J. C. Jensenius. 2007. Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun. 8:154-163.
52. Valles, X., M. R. Sarrias, F. Casals, M. Farnos, R. Piñer, B. Suarez, L. Morais, I. Mandomando, B. Sigauque, A. Roca, P. L. Alonso, A. Torres, N. M. Thielens, and F. Lozano. 2009. Genetic and structural analysis of MBL2 and MASP2 polymorphisms in South-Eastern African children. Tissue Antigens 74:298-307.
53. Vincent, J. L. 2004. Endpoints in sepsis trials: more than just 28-day mortality? Crit. Care Med. 32(5 Suppl.):S209-S213.
54. Vincent, J. L., Y. Sakr, C. L. Sprung, V. M. Ranieri, K. Reinhart, H. Gerlach, R. Moreno, J. Carlet, J. R. Le Gall, D. Payen, and the Sepsis Occurrence in Acutely Ill Patients Investigators. 2006. Sepsis in European intensive care units: results of the SOAP study. Crit. Care Med. 34:344-353.
55. Walsh, M. C., T. Boucier, K. Takahashi, L. Shi, M. N. Busche, R. P. Rother, S. D. Solomon, R. A. Ezekowitz, and G. L. Stahl. 2005. Mannose-bindig lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J. Immunol. 175:541-546.
56. Worthley, D. L., P. G. Bardy, and C. G. Mullighan. 2005. Mannose-binding lectin: biology and clinical implications. Intern. Med. J. 35:548-555.